Chronic Pain
Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
Decoding Cannabis: Over the limit, but not impaired? What the science shows
The UK (and many other countries) sets its drug-driving THC limit at 2 µg/L of blood, but is that a measure of impairment, or just detection? A 2026 simulator study found frequent cannabis users were no more impaired than non-users 12 to 15 hours after smoking, despite still exceeding that threshold. We decode what the research really shows, and why it is relevant for medical cannabis patients who are worried about getting behind the wheel.
8 min read
04.06.2026
Sam North
Quick reads
Articles
Decoding Cannabis: Over the limit, but not impaired? What the science shows
The UK (and many other countries) sets its drug-driving THC limit at 2 µg/L of blood, but is that a measure of impairment, or just detection? A 2026 simulator study found frequent cannabis users were no more impaired than non-users 12 to 15 hours after smoking, despite still exceeding that threshold. We decode what the research really shows, and why it is relevant for medical cannabis patients who are worried about getting behind the wheel.
8 min read
04.06.2026
Sam North
What 24 cancer patients told us about medical cannabis for symptom relief: findings from Releaf's 2025 UK patient survey
Releaf's 2025 UK Medical Cannabis Patient Survey is the largest survey of active UK medical cannabis patients ever conducted. Of the 1,669 respondents, 24 selected cancer-related as their primary condition category. All 24 reported an improvement in quality of life, 83.3% rated their treatment extremely, very, or moderately effective, 83.3% experienced no side effects, and 95.8% would recommend medical cannabis to others. Here is what these patients told us about managing their symptoms alongside conventional oncology care.
7 min read
03.06.2026
Sam North
114 patients picked up the phone: Inside the first four months of Releaf Protect legal helpline data
In the first four months of 2026, 114 Releaf patients picked up the phone to the Releaf Protect legal helpline. Across employment disputes, criminal procedure questions, and roadside concerns, the data reveals the everyday reality of being a legal medical cannabis patient in a system still catching up with the law.
7 min read
28.05.2026
Sam North
Decoding Cannabis: what the first placebo-controlled cannabis migraine trial means for patients in 2026
The first randomised, placebo-controlled trial of vaporised cannabis for migraine attacks has finally been published. Researchers at UC San Diego compared THC, CBD, a balanced combination, and placebo across 247 treated migraines. The balanced ratio came out clearly ahead, with sustained benefit at 24 and 48 hours and no serious adverse events. We unpack what the trial proves, where it falls short, and how the results sit alongside Releaf's UK patient survey data on medical cannabis for migraine.
8 min read
26.05.2026
Sam North